We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$10.5B
AUM Growth
+$2.57B
Cap. Flow
+$2.52B
Cap. Flow %
23.97%
Top 10 Hldgs %
3.28%
Holding
3,782
New
851
Increased
1,449
Reduced
1,127
Closed
344

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$38.7M
2
AMZN icon
Amazon
AMZN
+$33.2M
3
IP icon
International Paper
IP
+$32.8M
4
XYZ
Block Inc
XYZ
+$32.6M
5
COF icon
Capital One
COF
+$30.7M

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$28M
2
DKS icon
Dick's Sporting Goods
DKS
+$27.9M
3
LLY icon
Eli Lilly
LLY
+$24.9M
4
MTN icon
Vail Resorts
MTN
+$24.7M
5
ACN icon
Accenture
ACN
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Financials 13.65%
3 Industrials 12.55%
4 Consumer Discretionary 12.48%
5 Healthcare 12.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
3401
DELISTED
Centessa Pharmaceuticals
CNTA
$7K ﹤0.01%
632
+432
+216% +$5.81K
GHRS icon
3402
GH Research
GHRS
$2.08B
$7K ﹤0.01%
+300
New +$6.59K
HALL
3403
DELISTED
Hallmark Financial Services, Inc.
HALL
$7K ﹤0.01%
+154
New +$5.96K
IMPL
3404
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$7K ﹤0.01%
+800
New +$7.99K
LEAP
3405
DELISTED
Ribbit LEAP, Ltd.
LEAP
$7K ﹤0.01%
+700
New +$7.15K
DNUT icon
3406
Krispy Kreme
DNUT
$577M
$6K ﹤0.01%
317
-38,004
-99% -$558K
PRQR icon
3407
ProQR Therapeutics
PRQR
$265M
$6K ﹤0.01%
703
-24,058
-97% -$183K
HARP
3408
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$6K ﹤0.01%
80
-4,432
-98% -$302K
REUN
3409
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$6K ﹤0.01%
535
+55
+11% +$1.18K
ACHL
3410
DELISTED
Achilles Therapeutics
ACHL
$5K ﹤0.01%
1,010
-875
-46% -$5.3K
HTHT icon
3411
Huazhu Hotels Group
HTHT
$13B
$4K ﹤0.01%
100
-4,629
-98% -$202K
SLN
3412
Silence Therapeutics
SLN
$564M
$4K ﹤0.01%
+184
New +$4.26K
ELVT
3413
DELISTED
Elevate Credit, Inc.
ELVT
$4K ﹤0.01%
+1,200
New +$4.07K
DOC
3414
DELISTED
PHYSICIANS REALTY TRUST
DOC
$4K ﹤0.01%
200
-12,020
-98% -$221K
IREN icon
3415
Iris Energy
IREN
$14.7B
$3K ﹤0.01%
+195
New +$3.42K
TNXP icon
3416
Tonix Pharmaceuticals
TNXP
$192M
– –
0
– –
RBAC
3417
DELISTED
RedBall Acquisition Corp.
RBAC
$3K ﹤0.01%
+308
New +$3.08K
ADSE icon
3418
ADS-TEC Energy
ADSE
$889M
$2K ﹤0.01%
+234
New +$2.19K
AFMD
3419
DELISTED
Affimed
AFMD
$2K ﹤0.01%
44
-56
-56% -$3.46K
HHH icon
3420
Howard Hughes
HHH
$4.03B
$2K ﹤0.01%
20
-8,974
-100% -$785K
LVTX
3421
DELISTED
LAVA Therapeutics
LVTX
$2K ﹤0.01%
401
+300
+297% +$1.97K
PCT icon
3422
PureCycle Technologies
PCT
$1.45B
$2K ﹤0.01%
208
-1,947
-90% -$23.5K
AAC.U
3423
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$2K ﹤0.01%
+213
New +$2.13K
HUGS
3424
DELISTED
USHG Acquisition Corp.
HUGS
$2K ﹤0.01%
+200
New +$2.02K
EVO icon
3425
Evotec
EVO
$711M
$1K ﹤0.01%
+62
New +$1.45K
135 136
137
138 139

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q4 2021 Portfolio in Review

As of Q4 2021, Cubist Systematic Strategies held 3,782 positions worth $10.5B, up 32% from $7.94B the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

Cubist Systematic Strategies deployed $2.52B of net new capital in Q4 2021, opening 851 new positions and adding to 1,449 existing holdings. Its largest new stake was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Estee Lauder, an estimated $28M trimmed.

  • Cubist Systematic Strategies's largest Q4 2021 buy was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.
  • Cubist Systematic Strategies added most to Medtronic in Q4 2021, an estimated $38.7M increase.
  • Cubist Systematic Strategies's biggest Q4 2021 reduction was Estee Lauder, cutting an estimated $28M.
  • Cubist Systematic Strategies fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $5.95M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.3% of its $10.5B portfolio in Q4 2021.
  • Cubist Systematic Strategies opened 851 new positions and closed 344 in Q4 2021.
  • Cubist Systematic Strategies's portfolio value rose 32% quarter-over-quarter to $10.5B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.